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SputumA B S T R A C T
Objective/background: Collection of one spot and one morning sputum specimen is recom-
mended for tuberculosis (TB) drug resistance surveys. This was a retrospective analysis of
Mycobacterium tuberculosis cultures isolated from two spot sputum specimens collected
from smear positive TB patients in a TB drug resistance survey. It was conducted to under-
stand the value of a second specimen.
Methods: A TB drug resistance survey was conducted in the state of Tamil Nadu, India, to
estimate the prevalence of drug resistance among new sputum smear-positive (NSP) and
previously treated (PT) patients diagnosed in Revised National Tuberculosis Control
Program microscopy centers. A total of 2425 patients (1524 NSP and 901 PT cases) were
enrolled in the study. From these patients, two spot sputum specimens (C and D) were col-
lected within a period of 2 h. No preservative was added to sputum. The samples were
transported at ambient conditions without cold storage to the central laboratory for culture
of M. tuberculosis. Culture yield from each sample was computed and analyzed.
Results: The proportion of cultures retrieved from C and D specimens among NSP cases
(89.3% and 89.7%) and PT cases (90.8% and 90.3%) were similar. The culture grades of C
and D samples were comparable (chi-square test, 3560.135; p < .001) and the agreement
was moderate (kappa test, 0.454).
Conclusion: The findings of the study reveal the adequacy of single spot sputum specimen
from smear positive pulmonary TB patients for bacteriological examination in a quality-
assured TB laboratory to determine precisely the level of drug resistance in a province of
India.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).amoorthy
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Bacteriological examination of sputum specimens is consid-
ered the most appropriate method for the definitive diagnosis
of pulmonary tuberculosis (PTB) and detection of drug resis-
tance caused by Mycobacterium tuberculosis. Its compo-
nents—microscopy, culture methods, and drug-susceptibility
testing (DST) for anti-TB drugs—are established and are being
scaled up in many of the national TB control programs all
over the world for case detection, monitoring, and treatment,
and for drug-resistance surveillance. However, the number of
sputum specimens to be collected from PTB patients, the
logistics, including the biosafety, involved in ensuring their
transportation to the central laboratories, and the cost of lab-
oratory investigations constitute a huge financial burden for
TB programmanagers trying to accomplish their goals of ade-
quate health care services to TB patients. The World Health
Organization (WHO) and the International Union against
Tuberculosis and Lung Diseases initially recommended three
sputum specimens in an algorithm of Spot–Morning–Spot for
the diagnosis of PTB by sputum smear microscopy [1]. They
revised their decision and recommended the use of two spec-
imens in an algorithm of Spot–Morning for diagnosis of TB
after reviewing extensive data on the contribution of a third
specimen for case detection [2]. Other laboratory investiga-
tions have already shown the adequacy of a single sputum
specimen for diagnosis of PTB by Ziehl–Neelsen smear micro-
scopy [1,3,4]. Recently, the findings of a study in India have
informed the policy makers of the utility of using a single
specimen in bacteriological profiling of multidrug-resistant
TB patients during follow up investigations [5]. However, for
TB drug resistance surveys (DRSs)/surveillance, WHO has
until now recommended two sputum specimens for culture
and drug susceptibility of Mycobacterium tuberculosis, which
has been followed in several surveys [6–8]. In this retrospec-
tive analysis of the data, collected in a DRS conducted in
Tamil Nadu, India, following the WHO recommended guideli-
nes, the inference of adequacy of a single sputum specimen
for the bacteriological investigations in DRSs is presented
and discussed.
Materials and methods
A TB DRS, based on cross-sectional cluster survey as recom-
mended by World Health Organization [6], was conducted in
the state of Tamil Nadu, India, in 2011 to estimate the preva-
lence of drug resistance among new sputum smear-positive
(NSP) and previously treated (PT) cases diagnosed in Revised
National Tuberculosis Control Program microscopy centers
[8]. Its sample size was calculated based on the TB DRS data
available in one of the provinces in India, Gujarat (prevalence
of multidrug resistant-TB, 2% among NSP and 12% among PT
cases) [7], and it was estimated to be 1,680 for NSP and 992 for
PT cases, with 50% precision, 10% loss, and a design effect of 2.
Prior to the survey, training was given to all staff in the
periphery on all aspects of the survey, including sputum
collection, safe package and transportation of specimens,and documentation of information in the clinical information
form. From each sputum smear-positive PTB patient, diag-
nosed under the programmatic conditions, two additional
spot sputum specimens, collected within a period of 2 and
3 h (Specimens C and D), were transported, using existing
courier services, to the central laboratory (NIRT, Chennai,
India). The sputum specimens were not preserved with Cetyl
Pyridinium Chloride (CPC) and were transported under ambi-
ent conditions. The specimens were processed by modified
Petroff’s method and cultured on solid Lo¨wenstein–Jensen
(LJ) media. The culture isolates were subjected to DST by 1%
proportion method (economic variant) on LJ medium as per
the WHO guidelines. NIRT is being continuously monitored
externally by the coordinating supranational TB reference
laboratory at Antwerp, Belgium, to ensure the quality of
mycobacterial culture and DST. The quality and performance
indicators in the laboratory were monitored continuously on
a routine basis as described before [9].
The data were entered into a Microsoft Excel (Version 11.0
developed by Microsoft for Windows) spreadsheet and cross
verified by a statistician. The number of C and D specimens
received was enumerated and, the proportion of cultures
retrieved, contaminated and nontuberculous mycobacteria
isolated from NSP and PT cases, were calculated. A Z-
proportion test was done to determine the significance of
observed differences between the proportions. A two-way
table, comparing culture grades of paired specimens from
1518 NSP and 894 PT patients, was created after excluding
patients who produced a single specimen. Kappa statistics
was performed to find the agreement between C and D spec-
imens. Chi-square and Z proportion tests were performed to
determine the significance of differences between C and D
specimens.
Ethical statement
Informed patient consent was obtained from all the study
participants. The permission for the retrospective analysis
of the data was obtained from the institutional ethical
committee.
Results
A total of 2425 patients (1524 NSP and 901 PT cases) were
enrolled in the study. Of these, six NSP and seven PT cases,
were excluded as they produced single sputum specimen.
As the numbers excluded were very small, the pairs of sam-
ples from the remaining 1518 NSP and 894 PT cases (2412
cases in total) were included for the present comparison.
The proportion of cultures retrieved from C and D speci-
mens among NSP cases (89.3% and 89.7%) and PT cases
(90.8% and 90.3%) were very high. The numbers of M. tubercu-
losis isolated, contaminated cultures and nontuberculous
mycobacteria isolated from C and D specimens were not sig-
nificantly different among NSP and PT (Table 1).
The quantitative comparison of culture results between C
and D specimens, from NSP and PT cases, is given in Table 2.
Table 1 – Details of specimens received from patients in the survey.
New smear positive cases Z Previously treated cases Z
C D C D
Specimens received 1524 1518 — 901 894 —
After exclusion of single specimens 1518 1518 — 894 894 —
Culture positive 1355 (89.3%) 1361 (89.7%) .764 812 (90.8%) 807 (90.3%) .746
Culture negative 105 (6.9%) 103 (6.8%) .944 45 (5%) 42 (4.7%) .830
Culture contaminated 53 (3.5%) 48 (3.2%) .685 22 (2.5%) 35 (3.9%) .107
NTM 5 (0.3%) 6 (0.4%) .985 15 (1.7%) 10 (1.1%) .420
Note. Z = proportion statistic test at 5% level of significance.
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D samples. The chi-square test showed a significant associa-
tion (3560.135; p < .001) and kappa test showed a moderate
agreement between C and D specimens (0.454; p < .001).
Discussion
The guidelines for drug resistance surveillance and testing in
laboratories were developed as early as 1969 [10]. Later, to
have the comparable global data on drug resistance, WHO
framed guidelines to carry out a global drug resistance
surveillance program through its collaborating centers for
bacteriology of TB [6,11]. The guidance is to collect two spu-
tum samples from smear-positive patients enrolled under
national TB control programs and to perform DST in quality
assured reference laboratories. Accordingly, in Tamil Nadu
survey, two additional sputum specimenswere collected from
Ziehl–Neelsen-positive patients and transported to the cen-
tral laboratory to carry out culture and susceptibility testing.
This retrospective analysis of DRS was done to determine
the adequacy of single sputum specimen over the current rec-
ommendation of two (one spot and one morning) sputum
specimens in the TB DRSs. It showed an insignificant contri-
bution of second specimen (<2% additional yield) in isolation
of M. tuberculosis. It is evident that it is redundant to collect
and process as many as 2412 specimens to get additional
yield of 2% isolates. Evidently, when adopting a single
specimen, the workload will be decreased considerably in
TB reference laboratories of the province, which have limitedTable 2 – Quantitative comparison of culture grades between C
C specimen
1+ 2+ 3+
D specimen 1+ 183 81 29
2+ 92 287 197
3+ 43 172 878
Col 33 11 6
Neg 12 6 5
Cont 14 8 29
NTM 0 0 0
Total 377 565 1,144
Note. 1+ = growth of 20–100 colonies of mycobacteria on Lo¨wenstein–Je
+ = confluent or innumerable growth of mycobacteria on LJ; Cont = co
Neg = negative; NTM = nontuberculous mycobacteria.
Chi-square statistics, 3560.135; p < .001; kappa agreement, 0.454; p < .001.resources and capacity. The entire logistics involved in spu-
tum package and transportation will also be minimized. The
cost of processing specimens in the laboratory can be consid-
erably reduced. The patient noncompliance and nonadher-
ence to the study may also be reduced by resorting to single
spot specimen. Nonetheless, the real value of a spot sputum
specimen from smear-positive PTB patients for isolation and
DST of M. tuberculosis is yet to be ascertained in an exclusive
study. The guidance for two specimens was to avert the unex-
pected contamination/loss of specimens/loss of viability of
cultures in the very complex TB survey procedures. This can
be negated once the quality and performance indicators in
the reference laboratory, where the DRS is to be performed,
are ensured. Even if there is any shortfall due to loss of cul-
tures and eventual loss of DST results, additional patients
can be recruited to compensate the loss as is being practiced
in DRS.
In a study in a remote setting, a successful recovery (94.4%)
of M. tuberculosis was achieved with the BACTEC MGIT 960
system using a single sputum specimen, even though the
specimens were stored for a long time in the field and sent
to the reference laboratory without any chemical preservative
or decontamination prior to transport [12]. The authors rec-
ommended studies in other resource-limiting settings to con-
firm their finding. They further suggested inclusion of solid
culture media to augment recovery ofM. tuberculosis. The pre-
sent analysis revealed adequate recovery of (97%) of M. tuber-
culosis utilizing solid LJ media and using one sputum
specimen.and D sputum specimens.
Total
Col Neg Cont NTM
31 13 8 1 346
9 6 17 0 608
6 8 16 1 1,124
19 18 3 0 90
13 99 6 4 145
3 4 23 2 83
0 2 2 12 16
81 150 75 20 2,412
nsen medium (LJ); 2+ = growth of >100 colonies of mycobacteria; 3
ntamination; Col = growth of 1–19 colonies of mycobacteria on LJ;
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should be considered with caution for careful interpretation:
(1) the current survey utilized two spot samples; (2) the find-
ings cannot be extrapolated to liquid culture (MGIT 960 sys-
tem); and (3) the specimens must be transported to the
laboratory with in 72 h from the time of collection. Delay in
transportation lead to contamination which further leads to
loss of culture positivity. In this survey, majority of specimens
were transported within 48 h using the well-organized net-
work of courier services in this province.
Despite all the merits and demerits described above, the
outcome of this retrospective analysis of the data may inform
the decision makers to review the data collected in similar
surveys/surveillance and draw conclusions about the ade-
quacy of single specimen for future DRs/surveillances.
Conclusion
The findings of the study reveal the adequacy of a single spot
sputum specimen, without any preservative, from smear-
positive PTB patients enrolled in a TB control program, for
bacteriological examination in a quality assured TB labora-
tory to determine precisely the level of drug resistance in a
province.
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